ALTERED ENZYME-ACTIVITIES OF XENOBIOTIC BIOTRANSFORMATION IN KIDNEYS AFTER SUBCHRONIC ADMINISTRATION OF CHLORO-4-(DICHLOROMETHYL)-5-HYDROXY-2(5H)-FURANONE (MX) TO RATS
K. Heiskanen et al., ALTERED ENZYME-ACTIVITIES OF XENOBIOTIC BIOTRANSFORMATION IN KIDNEYS AFTER SUBCHRONIC ADMINISTRATION OF CHLORO-4-(DICHLOROMETHYL)-5-HYDROXY-2(5H)-FURANONE (MX) TO RATS, Toxicology, 100(1-3), 1995, pp. 121-128
Activities of the xenobiotic metabolizing enzymes were measured in the
liver, kidney, duodenum and lung microsomes and cytosol fractions of
Wistar rats after subchronic administration of chloro-4-(dichloromethy
l)-5-hydroxy-2(5H)-furanone (MX), a potent bacterial mutagen in chlori
nated drinking water. MX was administered by gavage at the dose level
of 30 mg/kg for 18 weeks (low dose), or at the dose level which was ra
ised gradually from 45 mg/kg for 7 weeks via 60 mg/kg for 2 weeks to a
clearly toxic dose of 75 mg/kg for 5 weeks (high dose). Microsomal an
d cytosolic preparations were made and the activities of 7-ethoxyresor
ufin-O-deethylase (EROD), pentoxyresorufin-O-dealkylase (PROD), NADPH-
cytochrome-c-reductase, UDP-glucuronosyltransferase (UDPGT) and glutat
hione-S-transferase (GST) were measured, Kidneys were affected most. A
dose-dependent decrease was observed in EROD (90% in males, 80% in fe
males at the high dose) and in PROD (58% in females, at the high dose)
in kidneys. An increase was, however, detected in kidney NADPH-cytoch
rome-c-reductase (66% in females at high dose), UDPGT (89% in males an
d 97% in females at high dose) and GST activities (56% in males and 50
% in females at high dose). MX caused only a few changes in the enzyme
activities of the liver. The EROD activity was decreased 25% to 37%,
both in the livers of males and females, but the total content of P450
s was not altered. Hepatic GST activity was elevated in females in a d
ose-dependent manner (31% and 44%). GST activity was elevated in duode
num in females (59%) at the high dose. There were no marked changes in
the enzyme activities in the lungs. MX was a weak inhibitor of EROD a
ctivity both in the liver and kidney microsomes in vitro, decreasing t
he EROD activity by 53% and 43%, respectively at the concentration of
0.9 mM. The results indicate that MX decreases the activity of phase I
metabolism enzymes, but induces phase II conjugation enzyme activitie
s, particularly in kidneys in vivo. It is possible that these changes
contribute;to metabolism of MX in kidneys and renders them susceptible
to MX in the course of repeated exposure.